Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 16/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3502575 | 0.84 | KDM4E (0.56) | EGLN1ALDH1A1KDM4E | |
| SCHEMBL8139304 | 0.84 | KDM4E (0.56) | EGLN1ALDH1A1KDM4E | |
| SCHEMBL25985620 | 0.83 | KDM4E (0.55) | EGLN1ALDH1A1KDM4E | |
| SCHEMBL12020192 | 0.83 | KDM4E (0.55) | EGLN1ALDH1A1KDM4E | |
| SCHEMBL253460 | 0.82 | ALDH1A1 (0.73) | EGLN1ALDH1A1 | |
| SCHEMBL344528 | 0.82 | ALDH1A1 (0.65) | EGLN1ALDH1A1KDM4E | |
| SCHEMBL27872555 | 0.82 | ALDH1A1 (0.77) | EGLN1ALDH1A1KDM4E | |
| SCHEMBL1759043 | 0.80 | ALDH1A1 (1.00) | EGLN1ALDH1A1KDM4E | |
| SCHEMBL2017299 | 0.80 | ALDH1A1 (0.60) | EGLN1ALDH1A1 | |
| SCHEMBL16131034 | 0.80 | SLC40A1 (0.53) | EGLN1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3654395-B9 | ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY | SFC CO LTD (KR) | 2024-11-06 | — | — | EP | disclosed |
| EP-3654395-B1 | ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY | SFC CO LTD (KR) | 2024-08-28 | — | — | EP | disclosed |
| CN-110832657-B | Organic light emitting device having high efficiency | SFC株式会社 | 2023-10-24 | — | — | CN | disclosed |
| US-11532792-B2 | Organic light emitting diode having high efficiency | SFC CO., LTD. (KR) | 2022-12-20 | — | — | US | disclosed |
| US-11532792-B2 | Organic light emitting diode having high efficiency | SFC CO., LTD. (KR) | 2022-12-20 | — | — | US | disclosed |
| EP-3654395-A1 | ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY | SFC Co., Ltd. (KR) | 2020-05-20 | — | — | EP | disclosed |
| EP-3654395-A1 | ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY | SFC Co., Ltd. (KR) | 2020-05-20 | — | — | EP | disclosed |
| US-20200127209-A1 | ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY | SFC CO., LTD. (KR) | 2020-04-23 | — | — | US | disclosed |
| US-20200127209-A1 | ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY | SFC CO., LTD. (KR) | 2020-04-23 | — | — | US | disclosed |
| CN-110832657-A | Organic light emitting element with high efficiency | SFC株式会社 | 2020-02-21 | — | — | CN | disclosed |
| US-6211376-B1 | HERPES VIRUS, CYTOMEGALO VIRUS, VARICELLA-ZOSTER VIRUS,EPSTEIN-BARR VIRUS | PHARMACIA & UPJOHN COMPANY | 2001-04-03 | — | — | US | disclosed |
| EP-0927164-A1 | 8-HYDROXY-7-SUBSTITUTED QUINOLINES AS ANTI-VIRAL AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 1999-07-07 | — | — | EP | disclosed |
| WO-1998011073-A1 | 8-HYDROXY-7-SUBSTITUTED QUINOLINES AS ANTI-VIRAL AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 1998-03-19 | — | — | WO | disclosed |
| US-4812565-A | ANTIHISTAMINE INTERMEDIATES | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-03-14 | — | — | US | disclosed |
| US-4810795-A | ANTIHISTAMINES | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-03-07 | — | — | US | disclosed |
| US-4727152-A | Intermediates useful in the preparation of fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof | A. H. ROBINS COMPANY, INC. (US) | 1988-02-23 | — | — | US | disclosed |
| US-4705853-A | ANTIHISTAMINES | A. H. ROBINS COMPANY, INC. (US) | 1987-11-10 | — | — | US | disclosed |
| US-4642343-A | ANTIHISTAMINES | A. H. ROBINS COMPANY, INCORPORATED (US) | 1987-02-10 | — | — | US | disclosed |
| US-4604388-A | Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof in a method of counteracting histamine | A. H. ROBINS COMPANY, INCORPORATED (US) | 1986-08-05 | — | — | US | disclosed |
| US-4592866-A | Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof | A. H. ROBINS COMPANY, INC. (US) | 1986-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11532792-B2 | Organic light emitting diode having high efficiency | CYBA, SLC1A2, MAOB | EGLN1 2853/4885ALDH1A1 38/4885KDM4E 2632/4885 |
| US-20200127209-A1 | ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY | CYBA, SLC1A2, MAOB | EGLN1 2853/4885ALDH1A1 38/4885KDM4E 2632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.